唑来膦酸-话题@MedSci

#唑来膦酸#

31篇内容 | 1143人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1379685, encodeId=c83a13e96857c, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=Endocrinol Diabetes Nutr：唑来膦酸盐对成人骨质疏松症患者的即刻和远期疗效, objectType=article, longId=146066, objectId=54a01460660b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54a01460660b, replyNumber=0, likeNumber=38, createdTime=2018-08-08, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54a01460660b, moduleTitle=Endocrinol Diabetes Nutr：唑来膦酸盐对成人骨质疏松症患者的即刻和远期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54a01460660b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379684, encodeId=610713e96842e, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=唑来膦酸辅助减少乳腺癌患者的骨折：AZURE（BIG 01/04）研究, objectType=article, longId=136868, objectId=d647136868ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d647136868ef, replyNumber=0, likeNumber=31, createdTime=2018-05-01, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d647136868ef, moduleTitle=唑来膦酸辅助减少乳腺癌患者的骨折：AZURE（BIG 01/04）研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d647136868ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379683, encodeId=3ebd13e9683e6, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=Lancet oncol：狄诺塞麦对比唑来膦酸治疗新确诊的多发性骨髓瘤患者的骨骼症状的效果对比, objectType=article, longId=129661, objectId=5400129661c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5400129661c9, replyNumber=0, likeNumber=30, createdTime=2018-02-13, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5400129661c9, moduleTitle=Lancet oncol：狄诺塞麦对比唑来膦酸治疗新确诊的多发性骨髓瘤患者的骨骼症状的效果对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5400129661c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379682, encodeId=01a513e968227, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=CMAJ：骨量减少的绝经后女性：唑来膦酸的抗吸收活性能持续多久？, objectType=article, longId=117576, objectId=5d7011e57605, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d7011e57605, replyNumber=0, likeNumber=45, createdTime=2017-10-27, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d7011e57605, moduleTitle=CMAJ：骨量减少的绝经后女性：唑来膦酸的抗吸收活性能持续多久？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d7011e57605)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379681, encodeId=b69a13e9681d5, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=JAMA Oncology：乳腺癌骨转移患者接受12周或4周周期唑来膦酸治疗的治疗效果比较, objectType=article, longId=105304, objectId=80151053046b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80151053046b, replyNumber=0, likeNumber=25, createdTime=2017-07-13, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80151053046b, moduleTitle=JAMA Oncology：乳腺癌骨转移患者接受12周或4周周期唑来膦酸治疗的治疗效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80151053046b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379680, encodeId=d1ec13e968038, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=J Bone Miner Res：唑来膦酸治疗佩吉特氏病患者的希望？, objectType=article, longId=98776, objectId=0c3b98e76a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c3b98e76a5, replyNumber=0, likeNumber=37, createdTime=2017-05-17, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c3b98e76a5, moduleTitle=J Bone Miner Res：唑来膦酸治疗佩吉特氏病患者的希望？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c3b98e76a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379679, encodeId=132613e967969, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=JAMA：唑来膦酸治疗间隔是4周好还是12周好, objectType=article, longId=86599, objectId=78b186599b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78b186599b8, replyNumber=0, likeNumber=36, createdTime=2017-01-06, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78b186599b8, moduleTitle=JAMA：唑来膦酸治疗间隔是4周好还是12周好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78b186599b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379678, encodeId=83c813e96786d, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=BMC Oral Health：静脉注射唑来膦酸盐的时间可影响非手术根管治疗的成功率, objectType=article, longId=63591, objectId=b12f6359116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b12f6359116, replyNumber=0, likeNumber=34, createdTime=2016-02-23, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b12f6359116, moduleTitle=BMC Oral Health：静脉注射唑来膦酸盐的时间可影响非手术根管治疗的成功率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b12f6359116)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379677, encodeId=c9a513e9677a5, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=JAMA Intern Med：唑来膦酸治疗女性骨质疏松症的疗效和安全性, objectType=article, longId=50117, objectId=04aa5011e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04aa5011e05, replyNumber=0, likeNumber=37, createdTime=2015-05-02, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04aa5011e05, moduleTitle=JAMA Intern Med：唑来膦酸治疗女性骨质疏松症的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04aa5011e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379676, encodeId=3d7613e967623, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=唑来膦酸每季度给药1次对乳腺癌患者或仍有效, objectType=article, longId=6992, objectId=52ed699286, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52ed699286, replyNumber=0, likeNumber=30, createdTime=2012-06-14, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52ed699286, moduleTitle=唑来膦酸每季度给药1次对乳腺癌患者或仍有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52ed699286)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379675, encodeId=4b5c13e967548, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=Cancer：唑来膦酸对骨转移乳腺癌患者无效, objectType=article, longId=3659, objectId=6de63659ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6de63659ed, replyNumber=0, likeNumber=39, createdTime=2012-01-08, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6de63659ed, moduleTitle=Cancer：唑来膦酸对骨转移乳腺癌患者无效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6de63659ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379674, encodeId=c37d13e967433, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=美国FDA增加密固达（唑来膦酸）新禁忌证, objectType=article, longId=3265, objectId=03d9326563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03d9326563, replyNumber=0, likeNumber=23, createdTime=2011-11-07, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03d9326563, moduleTitle=美国FDA增加密固达（唑来膦酸）新禁忌证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03d9326563)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379673, encodeId=93ed13e967395, content=<a href='/topic/show?id=6d8340012ff' target=_blank style='color:#2F92EE;'>#唑来膦酸#</a>, objectTitle=NEJM：唑来膦酸辅助疗法不能改善乳腺癌治疗, objectType=article, longId=3185, objectId=761531854d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=761531854d, replyNumber=0, likeNumber=26, createdTime=2011-10-17, rootId=0, userName=风铃821, userId=3307462, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=761531854d, moduleTitle=NEJM：唑来膦酸辅助疗法不能改善乳腺癌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=761531854d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

唑来膦酸

2020-05-29

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

Endocrinol Diabetes Nutr：唑来膦酸盐对成人骨质疏松症患者的即刻和远期疗效

2018-08-08

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

唑来膦酸辅助减少乳腺癌患者的骨折：AZURE（BIG 01/04）研究

2018-05-01

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

Lancet oncol：狄诺塞麦对比唑来膦酸治疗新确诊的多发性骨髓瘤患者的骨骼症状的效果对比

2018-02-13

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

CMAJ：骨量减少的绝经后女性：唑来膦酸的抗吸收活性能持续多久？

2017-10-27

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

JAMA Oncology：乳腺癌骨转移患者接受12周或4周周期唑来膦酸治疗的治疗效果比较

2017-07-13

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

J Bone Miner Res：唑来膦酸治疗佩吉特氏病患者的希望？

2017-05-17

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

JAMA：唑来膦酸治疗间隔是4周好还是12周好

2017-01-06

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

BMC Oral Health：静脉注射唑来膦酸盐的时间可影响非手术根管治疗的成功率

2016-02-23

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

JAMA Intern Med：唑来膦酸治疗女性骨质疏松症的疗效和安全性

2015-05-02

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

唑来膦酸每季度给药1次对乳腺癌患者或仍有效

2012-06-14

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

Cancer：唑来膦酸对骨转移乳腺癌患者无效

2012-01-08

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

美国FDA增加密固达（唑来膦酸）新禁忌证

2011-11-07

风铃821 (审核中...)

前往app查看评论内容

#唑来膦酸#

NEJM：唑来膦酸辅助疗法不能改善乳腺癌治疗

2011-10-17

科室
- - 订阅+
  - 更多科室
工具
服务